CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

Table 3 Association of gene expression with NLR, at baseline

Gene	n	Rho	p-value
Positively associated with NLR
CD39 (ENTPD1)	78	0.663	< 0.0001
PTEN	78	0.034	< 0.0001
MYD88	78	0.662	< 0.0001
MMP9	78	0.749	< 0.0001
Negatively associated with NLR
HLA-DRA	78	−0.473	< 0.0001
HLA-DPB1	78	−0.547	< 0.0001
HLA-DPA1	78	−0.558	< 0.0001
CD5	78	−0.557	< 0.0001
CD28	78	−0.578	< 0.0001
NFATC2	78	−0.660	< 0.0001
CD247	78	−0.610	< 0.0001
ZAP70	78	−0.723	< 0.0001
IL2RB	78	−0.499	< 0.0001
CD3E	78	−0.532	< 0.0001
CD3G	78	−0.558	< 0.0001
IL7R	78	−0.620	< 0.0001
TRAT1	78	−0.515	< 0.0001
CD40LG	78	−0.537	< 0.0001
CD3D	78	−0.525	< 0.0001
IL32	78	−0.511	< 0.0001

ISSN: 1479-5876